Motor Dysfunction

Treatment with an investigational subcutaneous combination therapy for Parkinson’s disease improved ‘good on’ time by almost 2 hours per day, was safe and efficacious with treatment effect similar across a range of subgroups.

An analysis of data collected by the National NeuroAIDS Tissue Consortium, or NNTC, showed that complex motor dysfunction remains common among patients with HIV and is associated with cerebrovascular disease, AIDS-related CNS disorders and HIV-associated neurocognitive disorder, researchers reported.